Generated: January 20, 2018
DrugPatentWatch Database Preview
Patent Applications for URSODIOL
« Back to Dashboard
US Patent Applications for URSODIOL
|US Patent Application
||Patent Filing Date
||Patent Application Status
|➤ Subscribe||➤ Subscribe||FATTY ACID-PHARMACEUTICAL AGENT CONJUGATES||2000-12-05||Patented Case||2003-05-21|
|➤ Subscribe||➤ Subscribe||Systemic administration of a therapeutic preparation||2000-12-06||Abandoned -- Failure to Respond to an Office Action||2003-06-06|
|➤ Subscribe||➤ Subscribe||MEIOSIS REGULATING COMPOUNDS||2001-01-12||Patented Case||2002-05-31|
|➤ Subscribe||➤ Subscribe||SECRETORY LEUKOCYTE PROTEASE INHIBITOR DRY POWDER PHARMACEUTICAL COMPOSITIONS||1997-10-03||Abandoned -- Failure to Respond to an Office Action||2002-03-09|
|➤ Subscribe||➤ Subscribe||IMMUNOMODULATING COMPOSITIONS FOR TREATMENT OF IMMUNE SYSTEM DISORDERS||2001-01-17||Patent Expired Due to NonPayment of Maintenance Fees Under 37 CFR 1.362||2015-08-17|
|➤ Subscribe||➤ Subscribe||DERIVATIVES OF GLP-1 ANALOGS||1999-09-16||Patented Case||2002-09-12|
|➤ Subscribe||➤ Subscribe||Use of an angiogenesis inhibitor as a lead compound in drug development||2001-03-29||Abandoned -- Failure to Respond to an Office Action||2002-12-30|
|➤ Subscribe||➤ Subscribe||STRAINS OF BACTERIA AND PHARMACEUTICAL COMPOSITION CONTAINING ONE OR MORE OF SUCH STRAINS AND USE OF SAME FOR PREVENTING AND TREATING DISEASES ASSOCIATED WITH OR CAUSED BY ALTERED METABOLISM OF BILE ACIDS||2001-03-02||Abandoned -- After Examiner's Answer or Board of Appeals Decision||2010-09-30|
|➤ Subscribe||➤ Subscribe||Systemic administration of a therapeutic preparation||2001-02-14||Abandoned -- Failure to Respond to an Office Action||2003-06-06|
|➤ Subscribe||➤ Subscribe||METHOD AND APPARATUS TO EXERCISE DEVELOPMENTALLY DELAYED, PHYSICALLY AND/OR NEUROLOGICALLY IMPAIRED PERSONS||2001-05-02||Patent Expired Due to NonPayment of Maintenance Fees Under 37 CFR 1.362||2013-06-10|
| This preview shows a limited data set|
Subscribe for full access, or try a Trial
Serving leading biopharmaceutical companies globally:
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.